All content for The Biopharma Pod is the property of William Reed Ltd and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Brought to you by the team behind BioPharma-Reporter.com
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
The Biopharma Pod
5 minutes
12 years ago
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.
The Biopharma Pod
Brought to you by the team behind BioPharma-Reporter.com
